Published in Blood on March 01, 1982
Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci U S A (2002) 1.55
Biosynthesis of the subunits of factor VIIIR by bovine aortic endothelial cells. Proc Natl Acad Sci U S A (1983) 1.32
Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation. J Clin Invest (1984) 0.96
Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. J Clin Invest (1985) 0.93
Inhibition of disulfide bonding of von Willebrand protein by monensin results in small, functionally defective multimers. J Cell Biol (1985) 0.91
Role of carbohydrate in multimeric structure of factor VIII/von Willebrand factor protein. Proc Natl Acad Sci U S A (1983) 0.82
Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol (1976) 13.98
Proposals for the classification of the myelodysplastic syndromes. Br J Haematol (1982) 10.90
Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 6.82
NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med (1982) 4.70
A kaiC-interacting sensory histidine kinase, SasA, necessary to sustain robust circadian oscillation in cyanobacteria. Cell (2000) 3.31
CikA, a bacteriophytochrome that resets the cyanobacterial circadian clock. Science (2000) 2.50
Novel function for beta 1 integrins in keratinocyte cell-cell interactions. J Cell Biol (1990) 2.39
Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol (1991) 2.23
Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med (1985) 2.22
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol (1989) 2.13
Neurologic reactions after a therapeutic dose of mefloquine. N Engl J Med (1989) 2.03
Ectomesenchymal chondromyxoid tumor of the anterior tongue. Nineteen cases of a new clinicopathologic entity. Am J Surg Pathol (1995) 1.98
Studies on the purification and characterization of human factor 8. J Clin Invest (1972) 1.97
Heterogeneity of human whole blood platelet subpopulations. I. Relationship between buoyant density, cell volume, and ultrastructure. Blood (1977) 1.69
American Burkitt's lymphoma: a clinicopathologic study of 30 cases. II. Pathologic correlations. Am J Med (1975) 1.65
The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol (1981) 1.64
A cyanobacterial circadian timing mechanism. Annu Rev Genet (2003) 1.52
Coombs' positive reactions associated with sodium cephalothin therapy. JAMA (1967) 1.52
Plasma and platelet von Willebrand factor defects in uremia. Am J Med (1988) 1.42
Evaluation of the status of canine hydrotherapy in the UK. Vet Rec (2011) 1.37
Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. Br J Haematol (1973) 1.36
Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsies. Am J Hematol (1977) 1.27
The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain. J Clin Invest (1991) 1.26
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II. Clinical manifestations. Blood (1981) 1.25
Asialo von Willebrand factor interactions with platelets. Interdependence of glycoproteins Ib and IIb/IIIa for binding and aggregation. J Clin Invest (1985) 1.22
Chloroquine treatment of severe malaria in children. Pharmacokinetics, toxicity, and new dosage recommendations. N Engl J Med (1988) 1.22
Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa/IIa (alpha 2 beta 1-integrin). Blood (1994) 1.21
Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin. J Clin Invest (1977) 1.21
Fibrinogen competes with von Willebrand factor for binding to the glycoprotein IIb/IIIa complex when platelets are stimulated with thrombin. Blood (1984) 1.21
Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets. Blood (1981) 1.20
Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation (1995) 1.19
Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Ann Intern Med (1988) 1.19
American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival. Am J Med (1975) 1.15
Von Willebrand's disease: combined qualitative and quantitative abnormalities. N Engl J Med (1977) 1.14
A model of fulminant hepatic failure in the rabbit. Gastroenterology (1978) 1.12
Rapid spontaneous postpartum clearance of Plasmodium falciparum parasitaemia in African women. Lancet (1988) 1.11
Characteristics of blast crisis in chronic granulocytic leukemia. Blood (1977) 1.09
A variant form of hypergranular promyelocytic leukaemia (M3) Br J Haematol (1980) 1.09
Studies on the Factor VIII/von Willebrand factor antigen on human platelets. Thromb Res (1975) 1.08
In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIa von Willebrand's disease. Proc Natl Acad Sci U S A (1985) 1.08
Defibrination in acute pancreatitis. Ann Intern Med (1972) 1.08
Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. Blood (1975) 1.06
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release. J Clin Invest (1971) 1.06
Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease. J Clin Invest (1975) 1.03
Thrombocytopenia with sodium cephalothin therapy. Ann Intern Med (1972) 1.02
Danazol increases factor VIII and factor IX in classic hemophilia and Christmas disease. N Engl J Med (1983) 1.02
Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. N Engl J Med (1984) 1.02
Polyclonal B-cell lymphocytosis and hypergammaglobulinemia in patients with Gaucher disease. Am J Hematol (1988) 1.01
Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants. Science (1976) 1.01
Altered processing of integrin receptors during keratinocyte activation. Exp Cell Res (1991) 1.00
Immunological studies of factor VIII in haemophilia and von Willebrand's disease. Nat New Biol (1973) 1.00
Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med (1991) 1.00
Intravascular coagulation in acute leukemia: clinical and subclinical abnormalities. Blood (1972) 0.98
Acquired type I hyperlipoproteinemia with systemic lupus erythematosus, dysglobulinemia and heparin resistance. Am J Med (1969) 0.97
Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity. J Clin Invest (1978) 0.96
Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome. Am J Cardiol (1983) 0.96
Acute promyelocytic leukemia: a model for understanding the role of the malignant cell in hemostasis. Hum Pathol (1974) 0.95
Plasma cofactors of platelet function: correlation with diabetic retinopathy and hemoglobins Ala-c. Ann Intern Med (1978) 0.95
A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations. Blood (1981) 0.94
Colorimetric and thin-layer chromatographic methods for field assay of chloroquine and its metabolites in urine. Bull World Health Organ (1987) 0.93
Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor. J Clin Invest (1985) 0.93
Dysfibrinogenemia associated with hepatoma. Increased carbohydrate content of the fibrinogen molecule. N Engl J Med (1978) 0.93
Warfarin anticoagulation: difficulties in interpretation of the prothrombin time. Thromb Res (1982) 0.92
Studies of the human factor VIII/von Willebrand's factor protein I. Comparison of the protein found in normal, von Willebrand's disease and hemophilia A. Thromb Res (1975) 0.92
Role of surgery in the management of primary lymphoma of the gastrointestinal tract. J Surg Oncol (1996) 0.92
Selective binding of the factor VIII/von Willebrand factor protein to human platelets. Blood (1980) 0.92
Blast crisis of chronic granulocytic leukemia. Morphologic variants and therapeutic implications. Am J Med (1977) 0.92
Molecular biology of factor VIII/von Willebrand Factor. Thromb Haemost (1978) 0.92
Identification of platelet glycoprotein IIb/IIIa as the major binding site for released platelet-von Willebrand factor. Blood (1986) 0.92
von Willebrand factor binds specifically to sulfated glycolipids. J Biol Chem (1986) 0.91
Hemolytic anemia associated with cephalothin. JAMA (1971) 0.91
The Chediak-Higashi syndrome: continuous suspension cultures derived from peripheral blood. Blood (1969) 0.91
Urinary fibrin split products in lupus nephritis. Correlation with other parameters of renal disease. Arthritis Rheum (1974) 0.91
Conformational regulation of the fibronectin binding and alpha 3beta 1 integrin-mediated adhesive activities of thrombospondin-1. J Biol Chem (2001) 0.91
Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease. Blood (1986) 0.90
Attenuation and activation characteristics of steel and tungsten and the suitability of these materials for use in a fast neutron multileaf collimator. Med Phys (2001) 0.90
Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease. Blood (1987) 0.90
Activation of ATP-sensitive potassium channels contributes to reactive hyperemia in humans. Am J Physiol (1996) 0.90
Dominant inheritance of hemophilia A in three generations of women. Blood (1975) 0.89
Studies of the human factor VIII/von Willebrand's factor protein. II. Identification and characterization of the von Willebrand protein. Blood (1975) 0.88
Acute promyelocytic leukaemia: haemorrhagic manifestation and morphologic criteria. Br J Haematol (1975) 0.88
Field application of a colorimetric method of assaying chloroquine and desethylchloroquine in urine. Bull World Health Organ (1988) 0.88
Purification and characterization of human platelet von Willebrand factor. Br J Haematol (1994) 0.88
Myelofibrosis in chronic granulocytic leukemia. Blood (1971) 0.88
Increased expression of alpha 4 beta 1 and alpha 5 beta 1 integrins on HTLV-I-infected lymphocytes. Virology (1993) 0.88
Thrombosis with epsilon aminocaproic acid therapy. Am J Clin Pathol (1971) 0.87
Intravenous quinine therapy of hospitalized children with Plasmodium falciparum malaria in Kinshasa, Zaire. Am J Trop Med Hyg (1989) 0.87
Immunological studies of factor VIII (antihaemophiliac globulin) in haemophilia A. Nat New Biol (1971) 0.86
Identification of the thrombin receptor on human platelets by chemical crosslinking. J Clin Invest (1986) 0.86
Allelic variation of the β-, γ- and δ-kafirin genes in diverse Sorghum genotypes. Theor Appl Genet (2010) 0.86
Congenital dysfibrinogenemias. Ann Intern Med (1972) 0.86
Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids. J Biol Chem (1986) 0.86
Mechanisms underlying the morning increase in platelet aggregation: a flow cytometry study. J Am Coll Cardiol (1996) 0.85